Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors.

ABSTRACT:

Background

Insurance status predicts access to medical care in the USA. Previous studies have shown uninsured patients with some malignancies have worse outcomes than insured patients. The impact of insurance status on patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is unclear.

Patients and methods

A retrospective cohort study of adult patients with resected GEP-NETs was performed using the US Neuroendocrine Tumor Study Group (USNETSG) database (2000-2016). Demographic and clinical factors were compared by insurance status. Patients ≥ 65 years were excluded, as these patients are almost universally covered by Medicare. Kaplan-Meier and log-rank analyses were used for survival analysis. Logistic regression was used to assess factors associated with overa

SUBMITTER: Marincola Smith P 

PROVIDER: S-EPMC10182414 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature